Byron Donalds's Regeneron Pharmaceuticals ($REGN) trades
Yes. Byron Donalds has disclosed 4 trades in $REGN since 2021: 2 buys and 2 sales.
The most recently disclosed: a sale of $1K–$15K (up to $15K), made Apr 10, 2025 and disclosed May 24, 2025. From the close on May 24, 2025, the day it was disclosed, to the close on Oct 29, 2026, $REGN rose 35.7%. By disclosed buys of $REGN, Byron Donalds ranks No. 5 of the 13 people whose filings on Disclosed show trades in it: up to $30K.
- trades
- 4
- buys
- 2
- sales
- 2
- in buys
- up to$30K
Scan with your phone's cameraOpens the App Store or Google Play.Still held?
No, by the filings: the last sale on file, on Apr 10, 2025, was a full sale, and no purchase has been disclosed since.
Disclosed counts a position from the trades on file: each trade once, shares only, nothing after a full sale.
Every disclosed trade in $REGN
4 trades · newest filing first- Sold$1K–$15K(up to $15K)+35.7%since filed
- Sold$1K–$15K(up to $15K)+35.7%since filed
- Bought$1K–$15K(up to $15K)−1.2%since filed
- Bought$1K–$15K(up to $15K)−1.2%since filed
Each move runs from the close on the day the trade was disclosed to the close on Oct 29, 2026.
Byron's other most-traded stocks
Be there when Byron files next
Copy the portfolio and your basket follows each new filing.
Amounts are the ranges the filings disclose, and "up to" is the top of a range; the actual amount and price are not disclosed. Each row links to the filing it came from. This is a public record turned into a page, not a recommendation and not a statement about why anyone traded. Disclosed is not affiliated with Byron Donalds.